These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 779020)

  • 21. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.
    Andén NE
    J Pharm Pharmacol; 1972 Nov; 24(11):905-6. PubMed ID: 4405656
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of a high affinity transport system for dopamine in the median eminence and posterior pituitary.
    Demarest KT; Moore KE
    Brain Res; 1979 Aug; 171(3):545-51. PubMed ID: 476488
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of brain dopamine].
    Rybakowski J
    Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234
    [No Abstract]   [Full Text] [Related]  

  • 25. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fluorescence of dopamine terminals in rat brain during reproduction of conditioned defense reactions].
    Spiridonov VK
    Neirofiziologiia; 1979; 11(2):171-3. PubMed ID: 440491
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 29. Axonal transport in nigro-striatal and nigro-thalamic neurons: effects of medial forebrain bundle lesions and 6-hydroxydopamine.
    Fibiger HC; Pudritz RE; McGeer PL; McGeer EG
    J Neurochem; 1972 Jul; 19(7):1697-708. PubMed ID: 4114445
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
    Matthysse S
    Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical aspects of dopamine agonists.
    Kehr W; Carlsson A; Lindqvist M
    Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
    [No Abstract]   [Full Text] [Related]  

  • 33. [Functional role and pharmacological regulation of the dopaminergic system of the brain].
    Raevskiĭ KS
    Vestn Ross Akad Med Nauk; 1998; (8):19-24. PubMed ID: 9771125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
    Scatton B; Boireau A; Garret C; Glowinski J; Julou L
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
    [No Abstract]   [Full Text] [Related]  

  • 35. Mesencephalic dopamine neurons projecting to neocortex.
    Lindvall O; Björklund A; Moore RY; Stenevi U
    Brain Res; 1974 Dec; 81(2):325-31. PubMed ID: 4373129
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
    Ghose S; Crook JM; Bartus CL; Sherman TG; Herman MM; Hyde TM; Kleinman JE; Akil M
    Int J Neurosci; 2008 Nov; 118(11):1609-27. PubMed ID: 18853337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of central catecholamines: concluding remarks.
    Vogt M
    J Psychiatr Res; 1974; 11():183-4. PubMed ID: 4461789
    [No Abstract]   [Full Text] [Related]  

  • 38. Melanin formation by human brain in vitro.
    Rodgers AD; Curzon G
    J Neurochem; 1975 Jun; 24(6):1123-9. PubMed ID: 1127428
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of metergoline on delayed response in cats and its relation to the metabolism of dopamine and serotonin in neostriatal and mesolimbic neurons.
    Roberge AG; Roy JP; Boisvert C
    Exp Brain Res; 1978 May; 32(1):19-30. PubMed ID: 658185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New developments in the study of the mechanism of action of neuroleptics and amphetamine.
    Glowinski J
    J Psychiatr Res; 1974; 11():81-5. PubMed ID: 4156794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.